The binding of CAR T-cells to the target antigen also contributed to the binding of TNF-related apoptosis-inducing ligand (TRAIL) to death receptors such as DR4 and DR5 which are expressed on the surface of tumor cells, leading to the activation of the graft versus tumor effect [28]. The gene discussed is TNFSF10; the disease is neoplasm.